Many thanks to all 3 of them, to Juliette, to all families who participated, clinicians and all collaborators who made this long-term effort possible. 🙏
Many thanks to all 3 of them, to Juliette, to all families who participated, clinicians and all collaborators who made this long-term effort possible. 🙏
This study is the result of >10 years of work in my group, in close collaboration with Juliette Godin’s group at IGBMC, Strasbourg.
This study is the result of >10 years of work in my group, in close collaboration with Juliette Godin’s group at IGBMC, Strasbourg.
👉🏻Read the full preprint here:
www.medrxiv.org/content/10.1...
Below are the key findings 👇🏻
👉🏻Read the full preprint here:
www.medrxiv.org/content/10.1...
Below are the key findings 👇🏻
Amazing to see how different approaches led to outcomes that are both similar and wonderfully complementary 😊
Amazing to see how different approaches led to outcomes that are both similar and wonderfully complementary 😊
These papers describe a remarkable role for *recessive* variants in *RNU2-2* causing developmental and epileptic encephalopathy
🧵 by the amazing @christeldepienne.bsky.social 👇
1/3
📄 www.medrxiv.org/content/10.1...
These papers describe a remarkable role for *recessive* variants in *RNU2-2* causing developmental and epileptic encephalopathy
🧵 by the amazing @christeldepienne.bsky.social 👇
1/3
Our previous article: www.nature.com/articles/s41...
Our previous article: www.nature.com/articles/s41...
Amandine Santini
Benjamin Cogne
Myriam Essie
Clément Charenton
Camille Charbonnier
Gaetan Lesca
Caroline Nava
@hcmefford.bsky.social @nickywhiffin.bsky.social
@cwlaflamme.bsky.social
And many many others
Amandine Santini
Benjamin Cogne
Myriam Essie
Clément Charenton
Camille Charbonnier
Gaetan Lesca
Caroline Nava
@hcmefford.bsky.social @nickywhiffin.bsky.social
@cwlaflamme.bsky.social
And many many others
📄 www.medrxiv.org/content/10.1...
📄 www.medrxiv.org/content/10.1...
Our results support a continuum between dominant and recessive disorders and establish RNU2-2 DEE as nearly as frequent as ReNU syndrome (RNU4-2),
Our results support a continuum between dominant and recessive disorders and establish RNU2-2 DEE as nearly as frequent as ReNU syndrome (RNU4-2),
It often arises from a de novo variant in trans with an inherited allele, reflecting the high mutability of snRNA genes.
It often arises from a de novo variant in trans with an inherited allele, reflecting the high mutability of snRNA genes.
This revealed de novo (dominant) or biallelic (recessive) RNU2-2 variants in 126 individuals from 108 families.
This revealed de novo (dominant) or biallelic (recessive) RNU2-2 variants in 126 individuals from 108 families.
📄 www.medrxiv.org/content/10.1...
📄 www.medrxiv.org/content/10.1...
International study led by
@christeldepienne.bsky.social
145 ReNU syndrome individuals- T-loop variants associated with higher phenotypic severity and more 5'splice site disruption (19 cases).
35 cases/45 controls - identify a shared episignature.
#eshg2025 1/2
International study led by
@christeldepienne.bsky.social
145 ReNU syndrome individuals- T-loop variants associated with higher phenotypic severity and more 5'splice site disruption (19 cases).
35 cases/45 controls - identify a shared episignature.
#eshg2025 1/2
Meet some of them here: www.renusyndrome.org/renu-hope-vi...
❤️🥹
@anneotation.bsky.social @dgmacarthur.bsky.social @christeldepienne.bsky.social #renuCrew
Meet some of them here: www.renusyndrome.org/renu-hope-vi...
❤️🥹
@anneotation.bsky.social @dgmacarthur.bsky.social @christeldepienne.bsky.social #renuCrew
www.medrxiv.org/content/10.1...
A super fun collaboration with incredible duo @gregfindlay.bsky.social @joachimdejonghe.bsky.social from @crick.ac.uk
🧬🖥️🩺
🧵1/12
www.medrxiv.org/content/10.1...
A super fun collaboration with incredible duo @gregfindlay.bsky.social @joachimdejonghe.bsky.social from @crick.ac.uk
🧬🖥️🩺
🧵1/12